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Objective: To examine whether oxidative stress and the glycolytic switch are correlated to tumor grading,
tumor recurrence, and disease progression in urothelial carcinoma (UC) of the urinary bladder (UB).
Methods: All surgical specimens obtained from 27 patients (each containing their UC and normal tissues
of UB) were subjected to a pathological examination by computerized tomography, and a portion of each
specimen was used for the analysis of molecular biomarkers. The mRNA expression levels of pyruvate
dehydrogenase kinase-1 (PDK1), hypoxia-inducible factor 1 alpha (HIF-1a), lactate dehydrogenase A
(LDHA), pyruvate dehydrogenase, and glucose transporter protein 1 (Glut-1) were measured using
TaqMan-based real-time quantitative polymerase chain reaction. In addition, 8-hydroxy-2-
deoxyguanosine (8-OHdG) and the mitochondrial DNA (mtDNA) copy number were also determined.
Results: The 8-OHdG content and glycolytic genes expression were higher in UC of the UB than those in
the normal tissues of UB, whereas the mtDNA copy number was depleted. According to the multivariate
analysis, patients with Grade 3 tumors had higher expression levels of HIF-1a, LDHA, and Glut-1 than
those with Grades 1 and 2 tumors. In addition, patients with locally recurrent tumors had a higher
expression of HIF-1a and LDHA than those with nonrecurrent tumors. Furthermore, patients under
disease progression had higher levels of HIF-1a and PDK1 than those not under disease progression.
Conclusions: UC of the UB manifested that the glycolytic phenotype would reﬂect the Warburg effect. We
suggest that the molecular mechanism in the regulation of glycolytic switch in UC of the UB might
provide a speciﬁc biomarker for the future development of cancer diagnosis.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC. All rights reserved.1. Introduction
The occurrence of urothelial carcinoma (UC) of the urinary
bladder (UB) has the fourth highest incidence of all cancers in the
developed world, and patients with UC of the UB also suffer from
substantial morbidity and mortality.1 More than 90% of UB can-
cers present as transitional cell carcinoma, whereas approxi-
mately 5% are squamous cell carcinoma, and less than 2% are
adenocarcinoma.2 The majority of newly diagnosed cases are
conﬁned to the urothelium, which do not breach the laminai City Hospital Renai Branch,
C.
en).
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ttp://dx.doi.org/10.1016/j.uropropria and lead to superﬁcial invasion.3 UB cancer presents most
commonly as a noninvasive tumor including the frequently
recurring papillary carcinomas (Ta) and the more aggressive ﬂat
carcinoma in situ.4 The clinical outcomes of Ta tumors follow a
pathway that is usually distinct from carcinoma in situ and
invasive cancers (T1eT4). In addition, it has also been suggested
that Ta tumors have a high risk of local recurrence, whereas the
probabilities of disease progression and death increase with in-
vasion.4 This prognostic disparity highlights the importance of
early detection and therapeutic intervention, and hence it is
important to determine the molecular biomarkers involved in UB
cancer at different tumor stages and necessary for clinical diag-
nosis and assessment of treatments.5
Hypoxia is a pervasive microenvironmental factor that affects
normal development and disease progression in the human body.6an LLC. All rights reserved.
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tension (hypoxia), and under such conditions can induce adaptive
changes in tumor cell metabolism known as the Warburg effect.7
Hypoxia-inducible factor 1 (HIF-1a) is a critical regulatory protein
in the cellular response to hypoxia and is closely related to the
angiogenic process. Several glycolytic genes are regulated by HIF-
1a and result in the enhanced anaerobic glycolysis contributing to
the progression of cancers.7 Of note, HIF-1a can cause an increase in
the expression of pyruvate dehydrogenase kinase-1 (PDK1), which
causes the inhibition of pyruvate dehydrogenase (PDH) activity that
decreases the amount of pyruvate entering the citric acid cycle,
leading to decreased mitochondrial oxygen consumption rates.8
Chai et al9 found that an increase in HIF-1a expression was asso-
ciated with tumor size, histological grade, tumor invasiveness, and
recurrence in UC, and hence suggested that HIF-1a is a key regu-
lator of the angiogenic cascade and an independent prognostic
factor for disease-free survival in patients with UC. However, it
remains unknown as to whether the HIF-1a-regulated expression
of glycolytic genes is involved in the progression or the recurrence
of UC of the UB.
To the best of our knowledge, this is the ﬁrst report on the po-
tential role and the prognostic value of the mRNA expression of
HIF-1a-induced glycolytic genes that are expressed in superﬁcial
UC of the UB including PDK1, lactate dehydrogenase A (LDHA), and
glucose transporter protein 1 (Glut-1). By contrast, mitochondrial
dysfunction can explain the metabolic shift from mitochondrial
respiration to anaerobic glycolysis in cancer cells.10 In addition,
mitochondrial dysfunction-elicited reactive oxygen species (ROS)
can have a severe impact on the stability of mitochondrial DNA
(mtDNA) and nucleus DNA genome, which has been widely eval-
uated in various human cancers.11 An oxidative DNA damage
product, 8-hydroxy-20-deoxyguanosine (8-OHdG), is considered a
biomarker for various human tumors including UC of the UB.12,13
However, the change in mtDNA copy number, which would
reﬂect the mitochondrial function in UC of the UB, is still unknown.
Therefore, the second aim of this study was to investigate whether
oxidative stress-elicited mitochondrial dysfunction contributes to
UC of the UB indicated by the analysis of the copy number of
mtDNA and the 8-OHdG level in cancerous and normal tissues of
UB.Table 1
Primer sequences and TaqMan probes used in this study.
Gene name Primer sequence Probe number
ND1 FW: 50-ACCATTTGCAGACGCCATAA-30 a
RE: 50-TGAAATTGTTTGGGCTA CGG-30
18S FW: 50-TAGAGGGACAAG TGGCGTTC-30 a
RE: 50-CGCTGAGCCAGTCAGTGT-30
b-Actin FW: 50-ATTGGCAATGAGCGGTTC-30 11
RE: 50-GGATGCCACAGGACTCCAT-30
HIF-1a FW: 50-TTTTTCAAGCAGTAGGAATTGGA-30 66
RE: 50-TGATGTAGTAGCTGCATGATCG-30
PDK1 FW: 50-CAAGACCTCGTGTTGAGACCT-30 20
RE: 50-ACGTGATATGGGCAATCCAT-30
Glut-1 FW: 50-GGTTGTGCCATACTCATGACC-30 67
RE: 50-CAGATAGGACATCCAGGGTAGC-30
LDHA FW: 50-TCCTGCCGGCAAACTTAG-30 31
RE: 50-GCAGATTTGGCAGAGAGTATAATG-30
PDH FW: 50-CATCATCCTTTATTCCGTAAAGAC-30 74
RE: 50-TCCGAGAGGCAACAAGGTT-30
Glut1 ¼ glucose transporter 1; HIF-1a ¼ hypoxia-induced factor 1 alpha;
LDHA ¼ lactate dehydrogenase A; PDH ¼ pyruvate dehydrogenase; PDK1 ¼ PDH
kinase 1; ND1 ¼ NADH dehydrogenase subunit 1.
a No probes were used for SYBR green reactions in qPCR. Probe numbers indicate
the probes of the Universal Probe Set for Human in the LightCycler TaqMan Master
kit (Roche Applied Science) used in this study.2. Methods
2.1. Patients
A total of 27 fresh patients with UC of the UB who had ﬁrst
received transurethral resection of bladder tumor (TURBT) were
included in this study. All patients provided the signed informed
consent form prior to their surgeries according to the rules of the
Institutional Review Board of Taipei City Hospital. We used
continuous ﬂow resectoscope to perform TURBT. All surgical
specimens obtained from each patient including their cancerous
part (including tumor and tumor base) and perilesional part
(normal part) of UB tissues were sent for pathological examination
and conﬁrmation, and a portion of the tissues were immediately
kept in a liquid nitrogen tank for further analysis. The cauterized
tissue was eliminated using scissors carefully. Tumor grading
(Grades 1, 2, and 3) was reviewed by two pathologists. All of the
patients received regular follow-up including cystoscopy every 3
months for 3 years, every 6 months for 2 years, and annually after
5 years. If recurrence was noticed, repeated TURBT would be
performed. Intravesical chemotherapy (mitomycin) was per-
formed for all patients (weekly during the 1st month and monthly
for 1 year).Please cite this article in press as: Lai Y-W, et al., Enhanced oxidative st
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Total RNA from UB tissues was extracted with chloroform so-
lution after adding the TRIZol reagent (Sigma-Aldrich Chemical Co.,
St. Louis, MO, USA) and then precipitated with isopropanol solution
followed by dissolution of toxic substance in DEPCeH2O. An aliquot
of 2 mg RNAwas reverse-transcribed to cDNAwith the Ready-to-Go
reverse transcription-polymerase chain reaction (PCR) kit (Amer-
sham Biosciences, Uppsala, Sweden) at 42C for at least 16 hours.
Quantiﬁcation real-time PCR was performed using the LightCycler
TaqMan probe-based Master kit (Roche Applied Science, Man-
nheim, Germany) according to the manufacturer's instructions.14
The primer pairs and the number of probes used in this study
were designed by Universal ProbeLibrary Assay Design Center
(Roche), and are listed in Table 1. The threshold cycle (Ct) was
applied for the quantiﬁcation of gene expression in the tumor part
and the normal part from TCC of UB tissues. The Ct for each gene
expressionwas normalizedwith their 18S gene expression in TCC of
UB tissues, respectively, and then the ratio between the tumor part
and the normal part from each individual was determined for
further analysis.
2.3. Determination of the 8-OHdG content
The 8-OHdG content in total DNA from UB tissues was deter-
mined by using the 8-OHdG enzyme-linked immunosorbent assay
kit from Japan Institute for the Control of Aging (Fukuroi, Japan).
Total DNA from tissues was isolated using phenol/chloroform
extraction with the addition of butylated hydroxyl toluene (freshly
prepared in ethanol). After precipitating with ice-cold 75% ethanol,
we air-dried and dissolved isolated DNA in distilled water. After
pretreatment of sample according to the manufacturer's in-
structions,15 it was then subjected to analysis of the 8-OHdG con-
tent using the enzyme-linked immunosorbent assay kit, and the
detection range of the 8-OHdG concentration in a sample is
0.125e10 ng/ml.
2.4. Measurement of mtDNA copy number
The copy number of mtDNA in UB tissues was measured with a
real-time quantitative PCR (QPCR) technique using LightCyclerress and the glycolytic switch in superﬁcial urothelial carcinoma of
ls.2015.05.004
Table 2
Gene expression of HIF-1, PDK1, PDH, LDHA, and Glut-1, 8-OHdG and mtDNA copy
number in UC of UB with different grading (1, 2, and 3).
Grade 1 (n ¼ 8) Grade 2 (n ¼ 12) Grade 3 (n ¼ 7) p
HIF-1a* 1.82 ± 0.40 2.26 ± 0.40 3.15 ± 0.41 <0.01
PDK1 4.15 ± 2.47 5.12 ± 3.33 7.25 ± 2.69 0.78
LDHA* 2.01 ± 0.73 2.35 ± 0.87 7.13 ± 1.35 <0.01
PDH 1.57 ± 0.31 1.39 ± 0.34 1.28 ± 0.37 0.24
Glut-1* 2.05 ± 0.26 2.16 ± 0.42 4.22 ± 1.48 0.04
The ratio between cancerous and normal tissues of UB is expressed as mean ± SD.
The KruskaleWallis test was used for statistical analysis.
*p < 0.05 was considered statistically signiﬁcant.
Glut1 ¼ glucose transporter 1; HIF-1a ¼ hypoxia-induced factor 1 alpha;
LDHA ¼ lactate dehydrogenase A; mtDNA ¼ mitochondrial DNA; 8-OHdG ¼ 8-
hydroxy-2-deoxyguanosine; PDH ¼ pyruvate dehydrogenase; PDK1 ¼ PDH kinase
1; ND1 ¼ NADH dehydrogenase subunit 1; SD ¼ standard deviation; UB ¼ urinary
bladder; UC ¼ urothelial carcinoma.
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according to a method described previously.16 The relative copy
number of mtDNA in UB tissues was deﬁned by the normalization
of the crossing points (Cp value) in QPCR curves between the ND1
(mtDNA-encoded) and 18S rRNA (nuclear DNA-encoded) genes by
using the RelQuant software (Roche). The sequences of primers for
ND1 and 18S are outlined in Table 1.
2.5. Statistical analysis
We used the ManneWhitney test and KruskaleWallis test to
analyze the experimental data. SPSS 8.0 for Windows was used to
run the tests. A p value of <0.05 was considered statistically
signiﬁcant.
3. Results
The patients' ages ranged between 51 years and 80 years (mean
age61.2 years), and theywere followedup for ameandurationof18.5
months (range 12e36months). Of the 27 patients, 21weremale and
sixwere female; eightwereGrade 1,12wereGrade 2, and sevenwere
Grade 3. All of the patients were diagnosed to show superﬁcial
bladder cancer (20 were stage Ta and 7 were T1) by TURBT and
Computerized Tomography (CT). During the follow-up period,
recurrence was noticed in 11 patients (T1, n ¼ 3; Ta, n ¼ 8), whereas
four patients (T1, n ¼ 3; Ta, n ¼ 1) had disease progression (muscle
invasion or distant metastasis). Nomortality has been noted thus far.
The gene expression level of HIF-1a, PDK1, LDHA, PDH, and
Glut-1 in the normal part and the cancerous part of UB are shown in
Figure 1. We observed that the gene expression level of HIF-1a,
PDK1, LDHA, and Glut-1 were more than 2-fold higher in UC of the
UB than those in the normal tissues of UB (2.36-, 5.39-, 3.44-, and
2.66-fold, respectively), but the expression of PDH (1.41-fold)
showed no signiﬁcant difference between UC of the UB and normal
UB tissues. By multivariate analysis, we further found that patients
with higher tumor grading (Grade 3) had a higher level of HIF-1a,
LDHA, and Glut-1 expressions than those with Grade 1 and Grade 2
tumors (Table 2). In addition, patients with local recurrent tumorFig. 1. The upregulated expression of HIF-1a and HIF-1a-regulated glycolytic genes in
UC of UB compared with those of normal tissues. The mRNA genes expression in UB
tissues (including normal part and cancerous part) was quantiﬁed using TaqMan-based
real-time QPCR and the level of each gene was normalized to 18S ribosomal RNA. Data
are presented as means ± SD of the results from three experiments (*p < 0.05,
**p < 0.01 vs. the indicated group). HIF-1a ¼ hypoxia-inducible factor 1 alpha;
QPCR ¼ quantitative polymerase chain reaction; SD ¼ standard abbreviation;
UB ¼ urinary bladder; UC ¼ urothelial carcinoma.
Please cite this article in press as: Lai Y-W, et al., Enhanced oxidative st
urinary bladder, Urological Science (2015), http://dx.doi.org/10.1016/j.urowere found to show a higher expression of HIF-1a and LDHA than
those with nonrecurrent tumor (Table 3). Furthermore, patients
with disease progression had higher HIF-1a and PDK1 expression
levels (Table 4).
As shown in Figures 2 and 3, 8-OHdG in UC of the UB was
signiﬁcantly higher than that in each of the normal tissues of UB
(9.35 ± 1.75 vs. 6.20 ± 0.82), whereas the mtDNA copy number in
UC of the UB was signiﬁcantly lower than that of the normal tissues
of UB (0.093 ± 0.022 vs. 0.043 ± 0.026). However, after further
analysis of the differences with regard to tumor grading, tumor
recurrence and disease progression, no signiﬁcant differences were
found in each parameter (Tables 2e4).4. Discussion
It has been suggested that enhanced glycolysis in most
cancerous cells and tissues is accompanied with the tumorigenesis
termed theWarburg effect.7 The increased glycolytic metabolism of
cancer cells confers a selective advantage for survival and prolif-
eration in the unique tumor microenvironment (hypoxia condi-
tion). The role of HIF-1a is well-known factor involved in the
adaptive response in most cancerous cell types to the changes in
tissue oxygenation.8 Previously, a strong relationship between HIF-
1a immunoreactivity and the grade of the tumor in UB was
claimed.17 Accordingly, we observed in this study that highermRNA
expression of HIF-1a was found in UC of the UB, and more signif-
icantly related to the tumor grading, disease recurrence, and pro-
gression. Furthermore, we reported that the mRNA expressions of
HIF-1a-induced glycolytic genes including LDHA, Glut-1, and PDK1,
were all more than 2-fold higher in UC of the UB than those inTable 3
Gene expression of HIF-1, PDK1, PDH, LDHA, and Glut-1, 8-OHdG, mtDNA copy






HIF-1a* 2.12 ± 0.58 2.70 ± 0.59 0.02
PDK1 4.97 ± 4.25 5.99 ± 4.39 0.55
LDHA* 2.59 ± 0.37 4.68 ± 0.41 0.04
PDH 1.49 ± 0.32 1.31 ± 0.38 0.21
Glut-1 2.66 ± 2.53 2.67 ± 1.82 0.99
The ratio between cancerous and normal tissues of UB is expressed as mean ± SD.
The ManneWhitney test and Cox model were used for statistical analysis.
*p < 0.05 was considered statistically signiﬁcant.
Glut1 ¼ glucose transporter 1; HIF-1a ¼ hypoxia-induced factor 1 alpha;
LDHA ¼ lactate dehydrogenase A; mtDNA ¼ mitochondrial DNA; 8-OHdG ¼ 8-
hydroxy-2-deoxyguanosine; PDH ¼ pyruvate dehydrogenase; PDK1 ¼ PDH kinase
1; SD ¼ standard deviation; UB ¼ urinary bladder; UC ¼ urothelial carcinoma.
ress and the glycolytic switch in superﬁcial urothelial carcinoma of
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Table 4
Gene expression of HIF-1a, PDK1, PDH, LDHA, and Glut-1, 8-OHdG, mtDNA copy
number, tumor number, and diameter in UC of UB with or without disease
progression.
Disease progression
(e) (n ¼ 23)
Disease progression
(þ) (n ¼ 4)
p
HIF-1a* 2.28 ± 0.65 2.83 ± 0.33 0.03
PDK1* 5.31 ± 2.46 5.89 ± 1.49 0.04
LDHA 3.14 ± 3.13 5.19 ± 5.08 0.48
PDH 1.46 ± 0.34 1.18 ± 0.33 0.21
Glut-1 2.65 ± 2.38 2.75 ± 1.22 0.89
The ratio between cancerous and normal tissues of UB is expressed as mean ± SD.
The ManneWhitney test and Cox model was used for statistical analysis.
*p < 0.05 was considered statistically signiﬁcant.
Glut1 ¼ glucose transporter 1; HIF-1a ¼ hypoxia-induced factor 1 alpha;
LDHA ¼ lactate dehydrogenase A; mtDNA ¼ mitochondrial DNA; 8-OHdG ¼ 8-
hydroxy-2-deoxyguanosine; PDH ¼ pyruvate dehydrogenase; PDK1 ¼ PDH kinase
1; SD ¼ standard deviation; UB ¼ urinary bladder; UC ¼ urothelial carcinoma.
Fig. 3. Decrease in mtDNA copy number in UC of UB compared with those of normal
tissues. The mtDNA copy number in UB tissues (including normal part and cancerous
part) was determined using SRBR Green-based real-time QPCR. Data are presented as
means ± SD of the results from three experiments (**p < 0.01 vs. the indicated group).
mtDNA ¼ mitochondrial DNA; QPCR ¼ quantitative polymerase chain reaction;
SD ¼ standard abbreviation; UB ¼ urinary bladder; UC ¼ urothelial carcinoma.
Y.-W. Lai et al. / Urological Science xxx (2015) 1e64normal tissues of UB. We suggest that the observation of glycolytic
switch in UC of the UB may reﬂect the Warburg effect (Figure 4).7,18
Recently, two single nucleotide polymorphisms in the HIF-1a,
P582S and A588T, were shown to cause signiﬁcantly higher tran-
scriptional activity than thewild type, and it has been reported that
patients with a variant allele of HIF-1a had signiﬁcantly worse poor
prognosis in UC of the UB than those without a variant allele.19
Therefore, HIF-1a-induced downstream targets, glycolytic genes,
may play a vital role on the progression and recurrence in UC of the
UB. Indeed, Zhou and coworkers20 reported that by immunohis-
tochemistry staining, the protein expressions of HIF-a and Glut-1 in
UC of bladder were signiﬁcantly higher than those in normal tissues
near the cancerous tissues. The positive expression of Glut-1 in the
UC of the UB tissue was 78%, and there also was a positive corre-
lation between the Glut-1 expression level and the grading of
cancer. In addition, Palit et al21 indicated that the up-expression of
Glut-1 in human bladder cancer was associated with a poor prog-
nosis and a low survival rate. Likewise, we report in this study that
not only HIF-1a and Glut-1, but also LDHA, were upregulated in the
UC of the UB tissues compared to those of normal UB tissues, andFig. 2. Increase in 8-OHdG content in UC of UB compared with those of normal tissues.
The level of oxidative DNA damage in UB tissues (including normal part and cancerous
part) was evaluated by 8-OHdG content, which was quantiﬁed using the 8-OHdG ELISA
kit according to previously described methods. Data are presented as means ± SD of
the results from three experiments (**p < 0.01 vs. the indicated group).
ELISA ¼ enzyme-linked immunosorbent assay; 8-OHdG ¼ 8-hydroxy-2-
deoxyguanosine; SD ¼ standard abbreviation; UB ¼ urinary bladder; UC ¼ urothelial
carcinoma.
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urinary bladder, Urological Science (2015), http://dx.doi.org/10.1016/j.urothat these three genes were all correlated to the UB tumor grading.
Furthermore, we also indicate that the upregulation of HIF-1a and
LDHA gene expression in UC of the UB was related to the local
recurrent tumor. It is also worth noting that LDHA was previously
reported to be preferentially expressed in tumors including lung,
breast, endometrium, and UB tissues, suggesting that those tumor
cells utilize anaerobic glycolysis as a means of energy production.22
Taken together, we suggest that there is a glycolytic switch occur-
ring in the UC of the UB, and the expression of HIF-1a and LDHA
genes would be a prognostic risk for UC of the UB with recurrence
or without recurrence (Figure 4). The number of the samples
assayed ex vivo was limited in this study, and hence, a further cell
model is required for investigating the detrimental effects of HIF-
1a-induced glycolytic switch in bladder cancer.
A key branch point in the glycolytic pathway is the production of
pyruvate, which in anaerobic conditions is metabolized to lactate
and in normoxia by PDH to acetyl-CoA. Accordingly, PDH activity is
controlled by PDH kinase (PDK), which phosphorylates and in-
activates its enzymatic activity.23 Intriguingly, it has been reported
that the hypoxia-inducible PDK1 is critical for the attenuation of
mitochondrial ROS production, maintenance of ATP levels, and
adaptation to hypoxia for the advantaged cancer survival.8 There is
a report showing that by immunochemistry staining, the upregu-
lation of PDK1 in head and neck squamous cancer is associatedwith
a poor prognosis.24 In our studies, we found a higher mRNA
expression of PDK1 gene in UC of the UB compared to those of
normal UB. Signiﬁcantly, we also investigated if a higher expression
of HIF-1a and PDK1 in patients with UC of the UB could have a
higher chance of disease progression. Taken together, we contend
that the striking and adverse outcome of UC of the UB with the
highest PDK1 expression may be a risk for disease progression
(Figure 4).
By contrast, mitochondrial dysfunction has been thought to play
a key role in tumorigenesis, and a wide spectrum of mutations and
depletion in mtDNA have been identiﬁed in several human can-
cers.10 At least in part, mitochondrial dysfunction can explain the
metabolic shift in cancer cells from mitochondrial respiration to
anaerobic glycolysis owing to the energy demand for cancer cells'
survival. Consequently, mitochondrial dysfunction-elicited ROS
could severely damage DNA molecules, resulting in the genomic
instability that contribute to tumorigenesis.25 8-OHdG, one of theress and the glycolytic switch in superﬁcial urothelial carcinoma of
ls.2015.05.004
Fig. 4. Overview of glycolytic shift in bladder cancer. Upregulated expression of glycolytic genes including HIF-1a, PDK1, LDHA, and Glut-1 are observed in UC of UB compared with
those of normal tissues, but not for PDH, a mitochondrial protein. The gene expression of HIF-1a is more signiﬁcantly related to tumor grading, disease recurrence, and progression.
Glut-1 ¼ glucose transporter protein 1; HIF-1a ¼ hypoxia-inducible factor 1 alpha; LDHA ¼ lactate dehydrogenase A; PDH ¼ pyruvate dehydrogenase; PDK1, pyruvate dehydro-
genase kinase-1; UB ¼ urinary bladder; UC ¼ urothelial carcinoma.
Y.-W. Lai et al. / Urological Science xxx (2015) 1e6 5major DNA base-modiﬁed products, is induced by hydroxyl radical,
singlet oxygen, or photodynamic action. Previously, Wada and
colleagues26 reported that the levels of 8-OHdG in bladder and
renal cancers tissues were signiﬁcantly higher than in the neigh-
boring noncancerous tissues. Our data are consistent with their
ﬁndings, but the increase in 8-OHdG in UC of the UB has no sig-
niﬁcant correlation with the tumor grading, disease recurrence, or
progression. However, it was reported by Soini et al27 that higher
levels of serum and urine 8-OHdG in patients with the UC of the UB
were associated with poor prognosis.
Mitochondrial dysfunction-elicited ROS can induce the alter-
ation of mtDNA copy number in different cancerous tissues, and
this effect has also been widely studied.28 It has been reported that
higher mtDNA copy number in whole blood was found to be
associated with increased risk of breast cancer,29 but a low mtDNA
copy number in whole blood was also reported to be associated
with renal cell carcinoma.30 The contradictory results suggest that
the role of mtDNA copy number in human cancer is complicated
and might be cancer site-speciﬁc. Of note, the decrease in mtDNA
copy number has been observed in lung cancer, hepatocellular
carcinoma, and gastric cancers, especially in lesions of advanced-
stage cancers.10 The decreased mtDNA copy number might be an
index of disease aggressiveness or progression in these human
cancers.10 Nevertheless, the observations of the present study for
the ﬁrst time reported that themtDNA copy number in UC of the UB
was lower than that in the normal tissues of UB, even though no
signiﬁcant difference was observed between tumor grading, pro-
gression, and recurrence of tumors.
In conclusion, the glycolytic shift that we demonstrated in UC of
the UB might provide a speciﬁc biomarker for the future develop-
ment of cancer diagnosis. We suggest that higher expression levels
of HIF-1a and PDK1 in patients with superﬁcial UC of the UB might
imply that they have a higher risk of disease progression and poor
prognosis.Conﬂicts of interest
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